Rational design of viral vectors based on rigorous analysis of capsid structures

Molecular Therapy

Volumn 1, Issue 1, 2000, Pages 3-4

  Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; GENE THERAPY; GENE VECTOR; GENETIC PROCEDURES; GENETICS; HUMAN; HUMAN ADENOVIRUS; NOTE; ULTRASTRUCTURE; VIRUS CAPSID;

ADENOVIRUSES, HUMAN; CAPSID; GENE THERAPY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS;

EID: 0033655675     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1006/mthe.1999.0004     Document Type: Note

References (15)

1. Douglas, J. T., and Curiel, D. T. (1995). Targeted adenoviral vectors for cancer gene therapy. Int. J. Oncol. It: 341-348.
2. Reynolds, P. N., and Curiel, D. T. (1998). Strategies to adapt adenoviral vectors for gene therapy applications: Targeting and integration. In The Development of Human Gene Therapy (T. Friedmann, Ed.), pp. 111-130. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
3. Arai, T., Matsumoto, K., Saitoh, K., Ui, M., Ito, T., Murakami, M., Kanegae, Y., Saito, I., Cosset, F. L., Takeuchi, Y., and Iba, H. (1998). A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J. Virol. 72(2): 1115-1121.
4. Wilson, C., Reitz, M. S., Okayama, H., and Eiden, M. V. (1989). Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J. Virol. 63(5): 2374-2378.
5. Johnson, J. E., Schnell, M. J., Buonocore, L., and Rose, J. K. (1997). Specific targeting to CD41 cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J. Virol. 71(7): 5060-5068.
6. Nilson, B. H., Morling, F. J., Cosset, F. L., and Russell, S. J. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther. 3: 280-286.
7. Kabat, D. (1995). Targeting retroviral vectors to specific cells. Science 269: 417.
8. Cosset, F. L., and Russell, S. J. (1996). Targeting retrovirus entry. Gene Ther. 3: 946-956.
9. Michael, S. I., Hong, J. S., Curiel, D. T., and Engler, J. A. (1995). Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2: 660-668.
10. Wickham, T. J., Tzeng, E., Shears, L. L., Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonova, A., and Kovesdi, I. (1997). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71: 8221-8229.
11. Henry, L. J., Xia, D., Wilke, M. E., Deisenhofer, J., and Gerard, R. D. (1994). Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68(8): 5239-5246.
12. Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., and Curiel, D. T. (1998). An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72: 9706-9713.
13. Vanderkwaak, T. M., Wang, M., Navarro, J. G., Rancourt, C., Dmitriev, I., Krasnykh, V., Barnes, M., Siegal, G. P., Alvarez, R. D., and Curiel, D. T. (1999). An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. Gyn. Oncol. 74: 227-234.
14. Kasono, K., Blackwell, J. L., Douglas, J. T., Dmitriev, I., Strong, T. V., Reynolds, P., Kropf, D. A., Carroll, W. R., Peters, G. E., Bucy, R. P., Curiel, D. T., and Krasnykh, V. (1999). Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin. Cancer Res. 5: 2571-2579.
15. Ruex, J. J., and Burnett, R. M. (1999). Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol. Ther. 1: 000-000.